![](/f/section_banner/144/1920p0/news_banner.png)
![Yes We Can 1+1 End Cervical Cancer Movement](/f/press_release/1002/536c302/20240422-PandaMan_1160-2.jpg)
Yes We Can 1+1 End Cervical Cancer Movement
Press ReleaseApril 24, 2024
More Than 50% of Women in Hong Kong Have Never Received Cervical Cancer Screening
Press ReleaseNovember 16, 2023
![INDICAID COVID-19 Rapid Antigen Test Authorized for Use in Japan](/f/press_release/882/536c302/23.08.04%20Japan%20Ag%20approval.png)
INDICAID COVID-19 Rapid Antigen Test Authorized for Use in Japan
Press ReleaseAugust 4, 2023
![INDICAID COVID-19 Rapid Antigen At-Home Test Authorized for Use by Health Canada](/f/press_release/871/536c302/23.07.05%20RAT%20approval%20in%20Canada.png)
INDICAID COVID-19 Rapid Antigen At-Home Test Authorized for Use by Health Canada
Press ReleaseJuly 5, 2023
PHASE Scientific Unveils World-first, Hong Kong-developed, Ground-breaking Urine DNA Concentration Technology for Early HPV Detection to Curb Cervical Cancer
Press ReleaseJuly 1, 2023
![INDICAID COVID-19/FLU A&B Rapid Antigen Test Authorized for Use by the Ministry of Health of New Zealand](/f/press_release/863/536c302/23.06.09%20COMBO%20NZ%20approval.png)
INDICAID COVID-19/FLU A&B Rapid Antigen Test Authorized for Use by the Ministry of Health of New Zealand
Press ReleaseJune 9, 2023